[go: up one dir, main page]

DK461689D0 - Anvendelse af aktive stoffer med seritoninagonistisk virkning til fremstilling af laegemidler med apoplexia cerebri - Google Patents

Anvendelse af aktive stoffer med seritoninagonistisk virkning til fremstilling af laegemidler med apoplexia cerebri

Info

Publication number
DK461689D0
DK461689D0 DK461689A DK461689A DK461689D0 DK 461689 D0 DK461689 D0 DK 461689D0 DK 461689 A DK461689 A DK 461689A DK 461689 A DK461689 A DK 461689A DK 461689 D0 DK461689 D0 DK 461689D0
Authority
DK
Denmark
Prior art keywords
active substances
seritoninagonistic
preparation
application
effect
Prior art date
Application number
DK461689A
Other languages
English (en)
Other versions
DK175128B1 (da
DK461689A (da
Inventor
Joerg Traber
Gerhard-Wilhelm Bielenberg
Original Assignee
Troponwerke Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troponwerke Gmbh & Co Kg filed Critical Troponwerke Gmbh & Co Kg
Publication of DK461689D0 publication Critical patent/DK461689D0/da
Publication of DK461689A publication Critical patent/DK461689A/da
Application granted granted Critical
Publication of DK175128B1 publication Critical patent/DK175128B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
  • Cephalosporin Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Instructional Devices (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pyridine Compounds (AREA)
DK198904616A 1988-09-20 1989-09-19 Anvendelse af aktive stoffer med seritoninagonistisk virkning til fremstilling af lægemidler med Apoplexia cerebri DK175128B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3831888A DE3831888A1 (de) 1988-09-20 1988-09-20 Arzneimittel zur behandlung von apoplexia cerebri
DE3831888 1988-09-20

Publications (3)

Publication Number Publication Date
DK461689D0 true DK461689D0 (da) 1989-09-19
DK461689A DK461689A (da) 1990-03-21
DK175128B1 DK175128B1 (da) 2004-06-07

Family

ID=6363313

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198904616A DK175128B1 (da) 1988-09-20 1989-09-19 Anvendelse af aktive stoffer med seritoninagonistisk virkning til fremstilling af lægemidler med Apoplexia cerebri

Country Status (15)

Country Link
US (3) US4988700A (da)
EP (1) EP0360077B1 (da)
JP (1) JP2669507B2 (da)
KR (2) KR0135307B1 (da)
AT (1) ATE91623T1 (da)
AU (1) AU619895B2 (da)
CA (1) CA1331139C (da)
DE (2) DE3831888A1 (da)
DK (1) DK175128B1 (da)
ES (1) ES2058426T3 (da)
FI (1) FI894404L (da)
HU (1) HU203475B (da)
IE (1) IE62697B1 (da)
IL (1) IL91660A (da)
PH (1) PH26920A (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930702976A (ko) * 1990-12-24 1993-11-29 개리 디. 스트리트 울증 및 조중의 치료에 있어서의 특정 글루타르이미드 유도체의 용도
DE4135473A1 (de) * 1991-10-28 1993-04-29 Bayer Ag Triazaspirodecanon-methylchromane
DE4138756A1 (de) * 1991-11-26 1993-05-27 Troponwerke Gmbh & Co Kg Kombination mit neuroprotektiver wirkung
EP0663014B1 (en) * 1992-09-25 2004-08-18 Synaptic Pharmaceutical Corporation Dna encoding human alpha 1 adrenergic receptors and uses thereof
AU5446894A (en) * 1992-10-23 1994-05-24 New York University Functional interactions between glial s-100b and central nervous system serotonergic neurons
AU765142B2 (en) 1998-06-01 2003-09-11 Ortho-Mcneil Pharmaceutical, Inc. Method for treating neurodegenerative disorders
AU4956699A (en) 1998-06-19 2000-01-05 Chiron Corporation Inhibitors of glycogen synthase kinase 3
US7045519B2 (en) * 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
JP2002520408A (ja) 1998-07-17 2002-07-09 シナプティック・ファーマスーティカル・コーポレーション ヒトα１ｄアドレナリン受容体に特異的な化合物およびその使用
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
DE19900544A1 (de) * 1999-01-11 2000-07-13 Basf Ag Verwendung von Verbindungen der Formel I zur Prophylaxe und Therapie der zerebralen Ischämie
US20040106623A1 (en) * 1999-07-16 2004-06-03 Synaptic Pharmaceutical Corporation Compounds specific for the human alpha1d adrenergic receptor and uses thereof
US7053092B2 (en) 2001-01-29 2006-05-30 Otsuka Pharmaceutical Co., Ltd. 5-HT1a receptor subtype agonist
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
US8703772B2 (en) 2001-09-25 2014-04-22 Otsuka Pharmaceutical Co., Ltd. Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
US20040002500A1 (en) * 2002-06-28 2004-01-01 Fabre Kramer Pharmaceutical, Inc. Methods for treating attention deficit disorder
US20040077996A1 (en) * 2002-10-22 2004-04-22 Jasperson Keith E. Drug infusion system with multiple medications
US7375219B2 (en) 2005-04-13 2008-05-20 Neuraxon, Inc. Substituted indole compounds having NOS inhibitory activity
CA2643822A1 (en) * 2006-04-13 2007-10-25 Neuraxon, Inc 1,5 and 3,6- substituted indole compounds having nos inhibitory activity
EP2219449A4 (en) * 2007-11-16 2010-10-27 Univ Arizona State METHOD FOR THE TREATMENT OF EXPOSURE TO DAMAGING
JP2011503120A (ja) * 2007-11-16 2011-01-27 ニューラクソン，インコーポレーテッド 内臓痛を治療するためのインドール化合物および方法
CA2705833A1 (en) * 2007-11-16 2009-05-22 Subhash C. Annedi 3,5-substituted indole compounds having nos and norepinephrine reuptake inhibitory activity
KR102357405B1 (ko) 2021-05-07 2022-02-09 정진구 호흡기 운동기구

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8810748D0 (en) * 1988-05-06 1988-06-08 Beecham Wuelfing Gmbh & Co Kg Novel treatment

Also Published As

Publication number Publication date
HUT52699A (en) 1990-08-28
DE58904960D1 (de) 1993-08-26
EP0360077A2 (de) 1990-03-28
HU203475B (en) 1991-08-28
IE892990L (en) 1990-03-20
ATE91623T1 (de) 1993-08-15
EP0360077A3 (de) 1992-03-11
KR0135307B1 (ko) 1998-04-23
JP2669507B2 (ja) 1997-10-29
KR900004352A (ko) 1990-04-12
IE62697B1 (en) 1995-02-22
AU4145689A (en) 1990-03-29
DE3831888A1 (de) 1990-03-29
CA1331139C (en) 1994-08-02
PH26920A (en) 1992-12-03
US5155128A (en) 1992-10-13
KR0146486B1 (ko) 1998-08-17
JPH02121935A (ja) 1990-05-09
IL91660A0 (da) 1990-04-29
US4988700A (en) 1991-01-29
DK175128B1 (da) 2004-06-07
FI894404L (fi) 1990-03-21
IL91660A (en) 1993-08-18
AU619895B2 (en) 1992-02-06
DK461689A (da) 1990-03-21
EP0360077B1 (de) 1993-07-21
US5070102A (en) 1991-12-03
FI894404A0 (fi) 1989-09-18
ES2058426T3 (es) 1994-11-01

Similar Documents

Publication Publication Date Title
DK461689D0 (da) Anvendelse af aktive stoffer med seritoninagonistisk virkning til fremstilling af laegemidler med apoplexia cerebri
IT1105040B (it) 3-1h-tetrazol-5-il-4h-pirido 1,2-a pirimidin-4-oni sostituiti utili in particolare come agenti terapeutici per inibire le reazioni allergiche e procedimento per la produzione dei detti derivati
NO882560D0 (no) Midler for aa oeke transdermal stroemning av farmasoeytiske stoffer.
AR224243A1 (es) Procedimiento para aumentar la viscosidad de preparados cosmeticos,farmaceuticos y tecnicos
ES2061799T3 (es) Nuevo preparado medicamentoso y procedimiento para su preparacion.
DE3879853D1 (de) Klebstoffzusammensetzung, zusammensetzung mit kontrollierter wirkstofffreisetzung und system zur transdermalen anwendung von arzneien.
DK143588D0 (da) Substituerede 9-amino-tetrahydroacridiner, deres fremstilling og anvendelse som laegemidler
NL970023I1 (nl) Medicamenten voor behandeling van oogontsteking.
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
DK522186A (da) Melatoninmaterialer og deres anvendelser
IT1193431B (it) Procedimento per la preparazione di prodotti antispasmici da applicare alla pelle particolarmente contro gli spasmi muscolari
DK208784A (da) Farmaceutisk produkt til kontrolleret afgivelse af aktive stoffer til huden
DE69812100D1 (de) Adenosin enthaltendes arzneimittel
FR2537584B1 (fr) Pyrazoloquinoleines substituees particulieres, procede pour leur preparation, preparations pharmaceutiques contenant ces composes et leur application therapeutique
IT7967043A0 (it) Derivati di aza i biciclo 2 2 2 octano prodotti intermedi procedimento per la loro preparazione e loro applicazione come medicinali
PT89478B (pt) Processo para a preparacao de piridinas di-substituidas
DK116689D0 (da) Pyrroloquinolin- og pyrrolophenothiazin-carboxamider og beslaegtede forbindelser samt farmaceutiske praeparater indeholdende disse og deres anvendelse til fremstilling af laegemidler til behandling af inflammation eller andre prostaglandin- eller leukotrin-formidlede sygdomme
IT1194158B (it) Carbacicline,procedimento per la loro preparazione e loro impiego come medicinali
IT1184729B (it) Prodotti farmaceutico cosmetico,in particolare per la cura di acne e seborrea
NO179632C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat som inneholder podofyllotoksin
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
DE3583234D1 (de) Physiologische mittel zur steigerung der transdermalen freisetzung von arzneimitteln.
DK89289D0 (da) Anvendelse af 1,4-dihydropyridin-derivater til fremstilling af laegemiddel til afvaenning af alkoholister
IT1093702B (it) 2,4-diclorofenti-imidazolil-etanoni (oli),procedimento per la loro preparazione e loro impiego come prodotti medicinali
IT1133086B (it) Preparato medicinale per trattare carcinomi e procedimento per la sua produzione

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK